Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03093636 · ClinicalTrials.gov registry record · NA
Efficacy of inControl Advice: A Decision Support System (DSS) for Diabetes
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT03093636 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 80 participants.
The verdict
NCT03093636, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to reduce the frequency of hypoglycemia and severe hypoglycemic events in subjects who use insulin pens to treat their Type 1 Diabetes Mellitus (T1DM). Hypoglycemia is the number one fear of many individuals and families with someone who has type 1 diabetes, and this fear often prevents optimal glycemic control. It is expected that this protocol will yield increased knowledge about using a decision support system to help control the glucose level.
Interventions
- DEVICE Continuous Glucose Monitor (CGM)+Decision Support System (DSS)
- OTHER Continuous Glucose Monitor (CGM) alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-04-17 |
| Est. Completion | 2019-03-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03093636
The ClinicalTrials.gov registry entry for NCT03093636 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Continuous Glucose Monitor (CGM)+Decision Support System (DSS) is the first listed.
NCT03093636 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03093636 about?
NCT03093636 is a clinical study titled "Efficacy of inControl Advice: A Decision Support System (DSS) for Diabetes". The purpose of this study is to reduce the frequency of hypoglycemia and severe hypoglycemic events in subjects who use insulin pens to treat their Type 1 Diabetes Mellitus (T1DM). Hypoglycemia is the number one fear of many individuals and families with someone who has type 1 diabetes, and this fea...
What is the current status of trial NCT03093636?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2017-04-17. Estimated completion is 2019-03-19.
What interventions are being tested in trial NCT03093636?
The interventions under investigation include: Continuous Glucose Monitor (CGM)+Decision Support System (DSS) (DEVICE), Continuous Glucose Monitor (CGM) alone (OTHER).
Who is sponsoring clinical trial NCT03093636?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.